Industry News
Weak cells condemned to death by the innate immune system
Dec 08, 2014
The "survival of the fittest" principle applies to cells in a tissue - rapidly growing and dividing cells are the fit ones. Read More
Association between common prostate cancer treatment and decreased survival in older men
Dec 08, 2014
A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital. Read More
Empathetic health care a model for lesbian, bisexual women and marginalized populations
Dec 08, 2014
Sitting on an exam table in a flimsy gown can intimidate anyone. If you also happen to be lesbian, gay or bisexual, the experience can be even worse. Read More
Most elderly breast cancer patients receive unnecessary radiation
Dec 08, 2014
A new study reports that almost two-thirds of elderly women with breast cancer are receiving radiation treatments, when trial data supports the omission of such therapy. Read More
Empathetic health care a model for lesbian, bisexual women and marginalized populations
Dec 08, 2014
Sitting on an exam table in a flimsy gown can intimidate anyone. If you also happen to be lesbian, gay or bisexual, the experience can be even worse. Read More
Drug allergies reduced without compromising efficacy
Dec 07, 2014
An enzyme that usually triggers strong allergic reactions now circulates in the veins of a group of mice without alerting the immune system. Read More
Tumor microenvironment of hepatitis B virus-associated hepatocellular carcinoma
Dec 06, 2014
Hepatocellular carcinoma (HCC) is one of the few cancers in which a continued increase in incidence has been observed over recent years. Read More
FDA approves Blincyto to treat a rare form of acute lymphoblastic leukemia
Dec 05, 2014
The U.S. Food and Drug Administration has approved Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an... Read More
BeyondSpring Pharmaceuticals to conduct Phase 3 trial of lead candidate Plinabulin in NSCLC
Dec 05, 2014
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it plans to initiate a Phase 3 pivotal... Read More
More evidence for impact of lung cancer targeted therapy from practice-changing trial
Dec 05, 2014
An international study involving Manchester researchers has found that for previously untreated lung cancer patients with a particular genetic change, a new targeted therapy is better than standard... Read More
Previous Page Next Page